Item 5.07. Submission of Matters to a Vote of Security Holders.
On August 1, 2024, Oramed Pharmaceuticals Inc. (the "Company") held its 2024 Annual Meeting of Stockholders. The final voting results at the 2024 Annual Meeting of Stockholders are set forth below.
Proposal No. 1 - Re-election of Directors.
The stockholders re-elected the following directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal. The votes were as follows:
| Director Name | For | Against | Abstain |
Broker Non-Votes | ||||||||||||
| Dr. Daniel Aghion | 10,090,486 | 117,471 | 54,544 | 7,236,740 | ||||||||||||
| Dr. Miriam Kidron | 10,011,623 | 211,627 | 39,251 | 7,236,740 | ||||||||||||
| Nadav Kidron | 10,007,284 | 216,146 | 39,071 | 7,236,740 | ||||||||||||
| Dr. Arie Mayer | 9,688,466 | 529,929 | 44,106 | 7,236,740 | ||||||||||||
| Yehuda Reznick | 10,050,385 | 138,618 | 73,048 | 7,236,740 | ||||||||||||
| Leonard Sank | 9,435,858 | 764,562 | 62,081 | 7,236,740 | ||||||||||||
| Benjamin Shapiro | 10,120,322 | 112,399 | 29,780 | 7,236,740 |
Proposal No. 2 - Advisory Vote on the Compensation of the Company's Named Executive Officers.
The stockholders approved, on a non-binding, advisory basis, the compensation of the Company's Named Executive Officers as described in the proxy statement, including the "Compensation of Executive Officers and Directors" section, the related compensation tables and other narrative compensation disclosures. The votes were as follows:
| For | Against | Abstain | Broker Non-Votes | |||
| 9,171,779 | 1,016,334 | 74,388 | 7,236,740 |
Proposal No. 3 - Ratification of Independent Registered Public Accounting Firm for the 2024 Fiscal Year.
The stockholders ratified the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2024 fiscal year. The votes were as follows:
| For | Against | Abstain | Broker Non-Votes | |||
| 17,323,361 | 119,546 | 56,334 | - |